HomeDoc Technologies Baltic is currently implementing a project co-financed by the European Union.
HomeDoc Technologies Baltic is pleased to announce that following the positive decision of the European Regional Development Fund is currently implementing the European Union funded project “R&D related to COVID-19 – OXY ” No. 01.2.1-LVPA-T-858-01-0008 (hereinafter referred to as the project).
Project aim is to increase company’s innovation potential through COVID-19 related research and experimental development. During project implementation period a technology prototype will be developed to enable the development of medical devices for the effective diagnosis of COVID-19 based on large data analysis.
The Project is funded by the European Regional Development Fund under Priority 1 of the European Union Funds Investment Operational Program for 2014–2020 “Promotion of Research, Experimental Development and Innovation” No. 01.2.1-LVPA-T-858 measure “COVID-19 MTEP”. Funded as part of the European Union’s response to the COVID-19 pandemic.
The total value of the project is 1.023.604,50 EUR of which 818.883,60 EUR is funded by the European Regional Development Fund and the rest is the company’s own contribution. Planned completion of the project activities is at the end of 2021.
Legal entity name HomeDoc Technologies Baltic, UAB HomeDoc Technologies, Inc.